#cancer

As the HIV population ages, the cancer burden will shift away from those associated with AIDS and toward those connected to aging.

People who are living with both HIV and hepatitis C virus (HCV) have a higher risk of developing non-AIDS-defining cancers.

Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.

A look at a large cohort of Canadians with HIV and hepatitis C also examined modifiable factors associated with a reduced risk of death.

A recent study found that from 1995 to 2009, 10 percent of all deaths among a large cohort of people on HIV treatment were cancer-related.

The facts about the risks and benefits of drinking coffee.

Treating HIV early, before CD4s drop significantly, lowers the risk of infection-related cancers.

Highlights from research presented at the 52nd International Liver Congress in Amsterdam

One quarter of men and one fifth of women have high-risk strains of human papillomavirus (HPV) that can cause various cancers.

The increased risk of some virus-associated cancers, such as non–Hodgkin lymphoma, did not appear driven by increased sexual risk taking.

As AIDS-related cancers decline and the HIV population ages, the most common malignancies by 2030 will likely be those related to aging.

This elevated risk, seen among a group largely uncured of hep C, remained even when factoring out liver cancer.

People with HIV in British Columbia have a shorter life expectancy and spend longer living with illnesses compared with those without HIV.

But do Scott Gottlieb’s interests lie with drugmakers or patients?

However, unlike HIV-negative quitters, their lung disease risk remains highly elevated for at least five years after kicking the habit.

Highlights from the hep C–related studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle